Electrical muscle stimulation is not a free lunch

Treatment
PEM
Energy metabolism
Clinics offer EMS as ‘passive exercise’ for people who cannot exercise. It may engage the same pathway implicated in post-exertional malaise — and no trial has tested this.
Author

Yannick Loth

Published

October 15, 2026

If you cannot exercise, electrical muscle stimulation sounds appealing. A device contracts your muscles for you. You do not move. It gets marketed as passive exercise — a way to keep muscle without spending energy you do not have. We looked at the mechanism, and the phrase “passive” is doing more work than it can support.

1 What EMS actually does

Electrical muscle stimulation (EMS), and its nerve-targeted cousin NMES, send current through the skin to make a muscle contract. The muscle does mechanical work. That work has a metabolic cost. It also puts mechanical stress on the muscle fibres — and that is the part whose downstream consequences have been traced, as far as inflammation, so it is the part this post follows.

2 The finding

The evidence indicates that, at higher intensities, electrical stimulation provokes micro-trauma of the same kind as voluntary exercise — in healthy-muscle studies, broadly comparable to eccentric contraction — and drives the same damage-to-inflammation cascade that follows exercise-induced muscle damage.

That cascade is a candidate pathway implicated in post-exertional malaise, not a settled one. So there are grounds to think EMS engages it. The claim is not that EMS causes a crash in everyone. It is that the reassuring assumption — “this is passive, therefore it is PEM-neutral” — has never been tested.

Note also that “activating muscle” and “causing micro-trauma” are not the same mechanism. Low-intensity stimulation used for circulation or atrophy prevention, at a dose a deconditioned patient can tolerate, may never reach the damage threshold. Whether the protocols actually offered to patients reach it is unknown — and no ME/CFS study has measured it.

EMS-induced PEM is therefore a hypothesis worth testing, not a demonstrated effect.

3 What we do not know — and this is a lot

We are not going to overstate this. The evidence is graded weak, and the list of unknowns is longer than the reassuring one:

  • No clinical trial of EMS or NMES exists in ME/CFS. Nobody has measured what happens to PEM in this population.
  • The evidence is indirect. The micro-trauma and inflammatory findings come from general and animal work, not from ME/CFS patients.
  • The timescales do not match. Delayed-onset muscle soreness peaks in days. A PEM crash can run for weeks. That difference is unexplained.
  • The dose matters and is uncontrolled. Effect is intensity-dependent, and no protocol exists for this population.
  • There are legacy nulls. Older work found normal muscle force and normal contractile behaviour in some ME/CFS studies, which cuts against a clean story.
  • There is one harm case report. One, not a series.

So the claim is narrower than “EMS is dangerous”: the reassurance was never tested, and there is a mechanism that gives grounds for caution. That is a reason to measure, not a verdict.

4 What this means in practice

If a clinician offers you EMS as a safe, non-exertional option:

  • Treat it as an exertion, with a budget — not as rest.
  • The dose is set by the clinician or operator, not by you. You cannot “start low” yourself. Ask who controls intensity, duration, and frequency.
  • Watch for a delayed reaction, not an immediate one. PEM does not arrive during the session. There is no validated monitoring window, so agree one in advance — and agree a stopping rule: if a crash follows, stop and do not re-trial at that dose.
  • Remember that a normal force measurement does not mean the metabolic and recovery response is normal.
  • The unanswered question — is the problem central or peripheral? — is a question a trial would begin to answer. No trial exists.

Rest is the safe default after a crash. You are not obliged to add anything. As an ongoing strategy, though, stopping EMS and doing nothing may forgo an unproven benefit — whether EMS prevents deconditioning in ME/CFS is itself untested. We do not know the best alternative either: gentle movement inside your energy envelope, and pacing, are also under-evidenced in this population. They are simply the options the paper can currently support. Discuss any change with a clinician who understands PEM.

5 The general principle

Anything that makes a muscle work imposes a load, whoever or whatever sets it going. In an illness defined by an abnormal response to exertion, the label matters less than the mechanism.

This is the same rule we apply across every intervention in the paper: a plausible mechanism is not evidence of safety, and absence of a trial is not evidence of harm. Both are reasons to say “we do not know yet” — and to measure.